RuiYi
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2223 Avenida De La Playa Ste 205, La Jol...Phone Number
(858) 587-4815Website
www.ruiyibio.comRevenue
$5.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About RuiYi
RuiYiis focused on the discovery and development of novel antibody therapeutics withupsized potential that represent (1) first in class antibody therapeutics toGPCR targets validated with small molecules yet never successfully drugged and (2) best in class antibody therapeutics to validated targets for unique marketswith significant medical need. In addition to Gerilimzumab, RuiYi is advancing RYI-018, a first in class anti-CB1 inverse agonist for the treatment offibrotic and metabolic diseases, including nonalcoholic steatohepatitis (NASH). RuiYi discovered RYI-018 from its internal discovery efforts utilizing iCAPS(intramembranous Conformation Antigen Presenting System), the Company'sproprietary discovery platform. iCAPS has been unique in the discovery offunctional antibody therapeutics to G protein-coupled receptors (GPCRs). RuiYi's is based in La Jolla, California.Explore more
RuiYi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RuiYi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if RuiYi is spiking on competitors!
Funding: Get notified immidiatlly once RuiYi has new funding data
Product Launch: Get notified when RuiYi launches new products
Check if RuiYi has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on RuiYi recently announced quarterly report
RuiYi, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at RuiYi
Click to see if RuiYi had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at RuiYi
Find more new buyers
Compare Similar Companies to RuiYi
Compare insights from companies similar to RuiYi, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
RuiYi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
RuiYi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about RuiYi.
RuiYi financials insights
Gather financial insights about RuiYi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2009
Series A
$13M
2012
Series B
$15M
2014
Debt
$4M
RuiYi Tech Stack
A closer look at the technologies used by RuiYi
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RuiYi
Sign Up For FreeTo access detailed company insights
RuiYiis focused on the discovery and development of novel antibody therapeutics withupsized potential that represent (1) first in class antibody therapeutics toGPCR targets validated with small molecules yet never successfully drugged and (2) best in class antibody therapeutics to validated targets for unique marketswith significant medical need. I... Read More
